Ingrid

Ingrid is a company-side figure at the center of the confrontation over Harkness Pharmaceuticals’ research spending, concealed funding, and possible exposure to Blake’s allegations. As she questions Filippo Crosetti and later rejects a settlement with Blake, she presents the company’s position in terms of evidence, reputational risk, and financial scale—while her suspicions about a laptop bug show that she is alert to investigative pressure of her own.

Position within Harkness Pharmaceuticals

At a meeting in Harkness’s office, Ingrid takes the head of the table, with Hertha to one side and Jane to the other. She directs the discussion toward Filippo Crosetti, whom she identifies as an employee rather than a consultant, and asks him to account for the resources devoted to nanotechnology and bioelectronics. Her questions draw on an email she sent on the twelfth and on conversations with researchers whose work, she says, has no obvious connection to developing or improving pharmaceutical products.

Ingrid’s scrutiny extends beyond the stated research budget. She says she has reason to believe Filippo was the conduit for a vast package of additional funding without an apparent recorded source, which she suspects Jack Harkness arranged. She presses Filippo to explain the chemical application of the work, but he answers that he is not an accountant. The exchange places Ingrid between the company’s scientific operations and an unresolved financial trail, without establishing that she knows where the money ultimately went.

Response to the Nightingale account and Blake

The Nightingale account forms part of the larger dispute over money allegedly diverted from Quintagler Industries. Investigators say the account was opened in London and was small beside the billions allegedly taken through shell companies in tax havens. Holly Walsh, meanwhile, has received anonymous payments that enabled her to obtain Ditrimantelline, an experimental treatment for her multiple sclerosis. Her benefactor used the name Luscinia and warned that the arrangement had to remain anonymous; Holly feared the money might have come from a Harkness employee diverting company funds.

When Blake argues that the company should care whether Astrid is actually Jane Glasson, Ingrid rejects the case for a settlement. She says Blake has not demonstrated that Jane’s possible change of identity twenty-two years earlier poses a reputational threat, that the sum passing through the Nightingale account is insignificant in the company’s budget, or that Anna Marchant was planted in Holly’s life by Harkness. Her conclusion is that the company has no good reason to care whether Astrid is Jane. Jane refuses to confirm the identification, leaving Ingrid’s assessment of the evidence distinct from any admission by the person at its center.

Suspicion and investigative pressure

Ingrid also turns attention toward the investigators. She says she wants to know more about Gareth Lawler’s activities because she believes he may have put Blake up to planting a bug on her laptop. Jane responds by telling her to ask Blake directly, then takes out her phone and hurries toward Harkness’s desk. Ingrid’s suspicion is presented as a belief, not a demonstrated fact; the episode nevertheless shows that she treats covert access to company information as a live concern.

Character and narrative role

Ingrid’s interventions combine inquiry with containment. She asks for an account of research and unexplained funding, but when Blake seeks a settlement she narrows the issue to what can be proved and whether the disputed sums or allegations matter to the company. That position contrasts with her concern over a possible bug, which suggests that the threat she sees is not limited to formal reputational claims. Through Ingrid, the corporate confrontation becomes a contest over what counts as evidence, which questions the company considers consequential, and who gets to define the limits of its responsibility.